Advanced Cardiac Therapeutics, Inc.: Series B $5M

Posted in Q - 4Q08, R - MID ATLANTIC, R - NORTH EAST, Uncategorized, X - Anticoagulant, X - Device (Dialysis), X - Device (GI), XX - MI, XX - NH

Advanced Cardiac Therapeutics (Laguna Beach, CA) a development-stage electrophysiology and radiometry medical device company focused on energy delivery via catheters for cardiac ablation, closed a $5M Series b financing. Participants include NBGI Ventures.

Feb

2010

Zyngenia, Inc.: Series A $10M

Posted in I - Series A, Q - 4Q09, R - MID ATLANTIC, X - Antibody, X - Autoimmune, X - Oncology, X - Therapeutic Platform, XX - MD

Zyngenia (Rockville, MD) a pre-clinical stage biotherapeutics company focused on multi-specific antibodies for oncology and autoimmune disorders, closed a $10M Series A financing. Particpants include New Enterprise Associates.
Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb

Dec

2009

GlycoMimetics, Inc.: Series C $38M

Posted in I - Series C, Q - 4Q09, R - MID ATLANTIC, X - GlycoBiology, X - Inflammation, X - Oncology, X - Sickle Cell, XX - MD

GlycoMimetics (Gaithersburg, MD) a clinical-stage small molecule glycobiology company focused on cancer, inflammation and infectious disease, closed a $38M Series C financing. Participants include Genzyme Ventures, New Enterprise Associates, Novartis Venture Fund, Anthem Capital Management and Alliance Technology Ventures.
A more detailed company profile recently appeared on Life Science Deal Flow [HERE].

Nov

2009

Arginetix, Inc.: Series B $4.6M

Posted in I - Series B, Q - 3Q09, R - MID ATLANTIC, X - Cardiology, XX - MD

Arginetix (Baltimore, MD) a preclinical-stage pharmaceutical company focused on the small molecule inhibition of arginase for pulmonary arterial hypertension, closed a $4.6M Series B financing. Participants include Quaker BioVentures, MedImmune Ventures, Red Abbey Venture Partners, Maryland Health Care Product Development Corp. and Acidophil.

Oct

2009

Sleep Solutions, Inc.: Series F $20M

Posted in I - Series F, Q - 3Q09, R - MID ATLANTIC, X - Device (Diagnostic), X - Device (Sleep Apnea), XX - MD

Sleep Solutions (Glen Burnies, MD) a commercial-stage medical device and diagnostics company focused on obstructive sleep apnea, closed a $20M Series F financing. Participants include Quaker BioVentures, Johnson & Johnson Dev Corp., TPG Growth, MedVenture Associates, Emergent Ventures and Lava Ventures.

Aug

2009

Profectus BioSciences, Inc.: Series C $19M

Posted in I - Series C, Q - 3Q09, R - MID ATLANTIC, X - Vaccines, X - Virology, XX - MD

Profectus BioSciences (Baltimore, MD) a clinical-stage biopharmaceutical focused on the development of vaccines for chronic viral infections, closed a $5M Series C financing. Participants include Cross Atlantic Capital Partners.

Jul

2009

Zephyr Technology Corp.: Series B $2M

Posted in I - Series B, Q - 2Q09, R - MID ATLANTIC, X - TeleMedicine, XX - MD

Zephyr Technology (Annapolis, MD) a commercial-stage device company focused on real-time monitoring of human of physiological and biomechanical conditions, closed a $2M Series B financing. Participants include Motorola Ventures.

Mar

2009

GetWellNetwork, Inc.: Series C $10M

Posted in I - Series C, Q - 1Q09, R - MID ATLANTIC, X - Biomarker, X - TeleMedicine, XX - MD

GetWellNetwork (Bethesda, MD) a commercial stage telemedicine provider of interactive patient care solutions, closed a $10M Series C financing. Participants include Johnson & Johnson Development Corp., Valhalla Partners, Grosvenor Funds, Point Judith Capital and Village Ventures.

Dec

2008

Psyadon Pharmaceuticals, Inc.: Series A $8M

Posted in I - Series A, Q - 4Q08, R - MID ATLANTIC, X - CNS

Psyadon Pharmaceuticals (Germantown, MD) early-stage developer of glutamate transport modulation for CNS indications, closed a $8M Series A financing. Participants include New Enterprise Associates, Aberdare Ventures and Domain Associates.

Dec

2008

Nexeon MedSystems, Inc.: Series A $24M

Posted in I - Series A, Q - 4Q08, R - MID ATLANTIC, X - Cardiology, X - Device (Stent)

Nexeon MedSystems (Charleston, WV) developer of a suite of cobalt alloy coronary and peripheral stents, closed a $24M Series A financing. Participants include SurModics and Guidant Corp.

« Previous Entries

to top of page...